NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Crescendo Biologics’

3 April 2014

EMBL Ventures brings Crescendo Biologics Series A to £19.5m

news_spirogen_molecule_lrg The European Molecular Biology Laboratory’s venture arm has invested £2m in Crescendo Biologics to bring the company’s Series A round to a weighty £19.5m.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014